_id
6915f67ebc934aba376b241a
Ticker
SER
Name
Serina Therapeutics Inc
Exchange
NYSE MKT
Address
601 Genome Way, Huntsville, AL, United States, 35806
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://serinatherapeutics.com
Description
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Last Close
2.11
Volume
52311
Current Price
2.69
Change
0.002
Last Updated
2026-01-06T11:00:14.988Z
Image
-
Ipo Date
2018-11-29T00:00:00.000Z
Market Cap
22181252
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.996
Sentiment Sources
1
Rating
5
Target Price
13
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
17000
Gross Profit
-17000
Operating Expenses
6375000
Operating Income
-6392000
Interest Expense
6000
Pretax Income
-4595000
Net Income
-4585000
Eps
-0.44346648612051454
Dividends Per Share
-
Shares Outstanding
10664064
Income Tax Expense
-
EBITDA
-4572000
Operating Margin
-
Total Other Income Expense Net
1797000
Cash
8620000
Short Term Investments
1721000
Receivables
-
Inventories
-
Total Current Assets
11497000
Property Plant Equipment
892000
Total Assets
12413000
Payables
2731000
Short Term Debt
3051000
Long Term Debt
0
Total Liabilities
10819000
Equity
1760000
Bs_currency_symbol
USD
Depreciation
17000
Change In Working Capital
1396000
Cash From Operations
-3850000
Capital Expenditures
13000
Cash From Investing
-13000
Cash From Financing
6444000
Net Change In Cash
2579000
Cf_currency_symbol
USD
PE
-
PB
15.80222159090909
ROE
-260.5113636363636
ROA
-36.93708209135584
FCF
-3863000
Fcf Percent
-
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
1.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
17000
Quarters > 0 > income Statement > gross Profit
-17000
Quarters > 0 > income Statement > operating Expenses
6375000
Quarters > 0 > income Statement > operating Income
-6392000
Quarters > 0 > income Statement > interest Expense
6000
Quarters > 0 > income Statement > pretax Income
-4595000
Quarters > 0 > income Statement > net Income
-4585000
Quarters > 0 > income Statement > eps
-0.44346648612051454
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10339000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4572000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1797000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
8620000
Quarters > 0 > balance Sheet > short Term Investments
1721000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11497000
Quarters > 0 > balance Sheet > property Plant Equipment
892000
Quarters > 0 > balance Sheet > total Assets
12413000
Quarters > 0 > balance Sheet > payables
2731000
Quarters > 0 > balance Sheet > short Term Debt
3051000
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
10819000
Quarters > 0 > balance Sheet > equity
1760000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4585000
Quarters > 0 > cash Flow > depreciation
17000
Quarters > 0 > cash Flow > change In Working Capital
1396000
Quarters > 0 > cash Flow > cash From Operations
-3850000
Quarters > 0 > cash Flow > capital Expenditures
13000
Quarters > 0 > cash Flow > cash From Investing
-13000
Quarters > 0 > cash Flow > cash From Financing
6444000
Quarters > 0 > cash Flow > net Change In Cash
2579000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.44346648612051454
Quarters > 0 > ratios > PB
15.80222159090909
Quarters > 0 > ratios > ROE
-260.5113636363636
Quarters > 0 > ratios > ROA
-36.93708209135584
Quarters > 0 > ratios > FCF
-3863000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
130000
Quarters > 1 > income Statement > cost Of Revenue
16000
Quarters > 1 > income Statement > gross Profit
114000
Quarters > 1 > income Statement > operating Expenses
5679000
Quarters > 1 > income Statement > operating Income
-5565000
Quarters > 1 > income Statement > interest Expense
9000
Quarters > 1 > income Statement > pretax Income
-6462000
Quarters > 1 > income Statement > net Income
-6448000
Quarters > 1 > income Statement > eps
-0.6445421831267493
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
10004000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6437000
Quarters > 1 > income Statement > operating Margin
-4280.7692307692305
Quarters > 1 > income Statement > total Other Income Expense Net
-897000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6041000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7991000
Quarters > 1 > balance Sheet > property Plant Equipment
950000
Quarters > 1 > balance Sheet > total Assets
8941000
Quarters > 1 > balance Sheet > payables
1706000
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
7295000
Quarters > 1 > balance Sheet > equity
1802000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6462000
Quarters > 1 > cash Flow > depreciation
16000
Quarters > 1 > cash Flow > change In Working Capital
706000
Quarters > 1 > cash Flow > cash From Operations
-3750000
Quarters > 1 > cash Flow > capital Expenditures
46000
Quarters > 1 > cash Flow > cash From Investing
-46000
Quarters > 1 > cash Flow > cash From Financing
5570000
Quarters > 1 > cash Flow > net Change In Cash
1774000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6445421831267493
Quarters > 1 > ratios > PB
14.933829078801331
Quarters > 1 > ratios > ROE
-357.82463928967815
Quarters > 1 > ratios > ROA
-72.1172128397271
Quarters > 1 > ratios > FCF
-3796000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-29.2
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
17000
Quarters > 2 > income Statement > gross Profit
-17000
Quarters > 2 > income Statement > operating Expenses
5841000
Quarters > 2 > income Statement > operating Income
-5858000
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-4822000
Quarters > 2 > income Statement > net Income
-4813000
Quarters > 2 > income Statement > eps
-0.4933374333743337
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9756000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4805000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1036000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4267000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5754000
Quarters > 2 > balance Sheet > property Plant Equipment
977000
Quarters > 2 > balance Sheet > total Assets
6731000
Quarters > 2 > balance Sheet > payables
1188000
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
5172000
Quarters > 2 > balance Sheet > equity
1701000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4822000
Quarters > 2 > cash Flow > depreciation
17000
Quarters > 2 > cash Flow > change In Working Capital
455000
Quarters > 2 > cash Flow > cash From Operations
-4322000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
0
Quarters > 2 > cash Flow > cash From Financing
4917000
Quarters > 2 > cash Flow > net Change In Cash
595000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.4933374333743337
Quarters > 2 > ratios > PB
15.428359788359788
Quarters > 2 > ratios > ROE
-282.9512051734274
Quarters > 2 > ratios > ROA
-71.50497697221809
Quarters > 2 > ratios > FCF
-4322000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-14000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-14000
Quarters > 3 > income Statement > operating Expenses
5535000
Quarters > 3 > income Statement > operating Income
-5549000
Quarters > 3 > income Statement > interest Expense
17000
Quarters > 3 > income Statement > pretax Income
-2752000
Quarters > 3 > income Statement > net Income
-2740000
Quarters > 3 > income Statement > eps
-0.2548600130220445
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10751000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2679000
Quarters > 3 > income Statement > operating Margin
39635.71428571428
Quarters > 3 > income Statement > total Other Income Expense Net
2797000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3672000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5676000
Quarters > 3 > balance Sheet > property Plant Equipment
1048000
Quarters > 3 > balance Sheet > total Assets
6724000
Quarters > 3 > balance Sheet > payables
744000
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
6216000
Quarters > 3 > balance Sheet > equity
641000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2752000
Quarters > 3 > cash Flow > depreciation
56000
Quarters > 3 > cash Flow > change In Working Capital
-172000
Quarters > 3 > cash Flow > cash From Operations
-4589000
Quarters > 3 > cash Flow > capital Expenditures
5000
Quarters > 3 > cash Flow > cash From Investing
-5000
Quarters > 3 > cash Flow > cash From Financing
5031000
Quarters > 3 > cash Flow > net Change In Cash
437000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.2548600130220445
Quarters > 3 > ratios > PB
45.11730109204368
Quarters > 3 > ratios > ROE
-427.4570982839314
Quarters > 3 > ratios > ROA
-40.749553837001784
Quarters > 3 > ratios > FCF
-4594000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
328.14285714285717
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
56000
Annuals > 0 > income Statement > cost Of Revenue
194000
Annuals > 0 > income Statement > gross Profit
-138000
Annuals > 0 > income Statement > operating Expenses
16910000
Annuals > 0 > income Statement > operating Income
-17048000
Annuals > 0 > income Statement > interest Expense
526000
Annuals > 0 > income Statement > pretax Income
-11207000
Annuals > 0 > income Statement > net Income
-11141000
Annuals > 0 > income Statement > eps
-1.5139285228971329
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
7359000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-10487000
Annuals > 0 > income Statement > operating Margin
-30442.857142857145
Annuals > 0 > income Statement > total Other Income Expense Net
5841000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3672000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5676000
Annuals > 0 > balance Sheet > property Plant Equipment
1048000
Annuals > 0 > balance Sheet > total Assets
6724000
Annuals > 0 > balance Sheet > payables
744000
Annuals > 0 > balance Sheet > short Term Debt
193000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
6216000
Annuals > 0 > balance Sheet > equity
641000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11207000
Annuals > 0 > cash Flow > depreciation
194000
Annuals > 0 > cash Flow > change In Working Capital
-3316000
Annuals > 0 > cash Flow > cash From Operations
-17137000
Annuals > 0 > cash Flow > capital Expenditures
22000
Annuals > 0 > cash Flow > cash From Investing
-22000
Annuals > 0 > cash Flow > cash From Financing
13212000
Annuals > 0 > cash Flow > net Change In Cash
-3947000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.5139285228971329
Annuals > 0 > ratios > PB
23.879438377535102
Annuals > 0 > ratios > ROE
-1738.0655226209046
Annuals > 0 > ratios > ROA
-165.69006543723975
Annuals > 0 > ratios > FCF
-17159000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-306.4107142857143
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3153000
Annuals > 1 > income Statement > cost Of Revenue
90000
Annuals > 1 > income Statement > gross Profit
3063000
Annuals > 1 > income Statement > operating Expenses
6192000
Annuals > 1 > income Statement > operating Income
-3129000
Annuals > 1 > income Statement > interest Expense
558000
Annuals > 1 > income Statement > pretax Income
5269000
Annuals > 1 > income Statement > net Income
5269000
Annuals > 1 > income Statement > eps
0.6262264691155303
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8413889
Annuals > 1 > income Statement > income Tax Expense
-8000
Annuals > 1 > income Statement > EBITDA
5917000
Annuals > 1 > income Statement > operating Margin
-99.23882017126546
Annuals > 1 > income Statement > total Other Income Expense Net
8398000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7619000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
57000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7619000
Annuals > 1 > balance Sheet > property Plant Equipment
1349000
Annuals > 1 > balance Sheet > total Assets
8968000
Annuals > 1 > balance Sheet > payables
580000
Annuals > 1 > balance Sheet > short Term Debt
3672000
Annuals > 1 > balance Sheet > long Term Debt
2983000
Annuals > 1 > balance Sheet > total Liabilities
41262000
Annuals > 1 > balance Sheet > equity
-32294000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
5269000
Annuals > 1 > cash Flow > depreciation
90000
Annuals > 1 > cash Flow > change In Working Capital
81000
Annuals > 1 > cash Flow > cash From Operations
-2476000
Annuals > 1 > cash Flow > capital Expenditures
504000
Annuals > 1 > cash Flow > cash From Investing
-504000
Annuals > 1 > cash Flow > cash From Financing
10067000
Annuals > 1 > cash Flow > net Change In Cash
7087000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.6262264691155303
Annuals > 1 > ratios > PB
-0.541923859540472
Annuals > 1 > ratios > ROE
-16.315724283148572
Annuals > 1 > ratios > ROA
58.75334522747547
Annuals > 1 > ratios > FCF
-2980000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.9451316206787187
Annuals > 1 > health Score
39
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
500000
Annuals > 2 > income Statement > cost Of Revenue
145000
Annuals > 2 > income Statement > gross Profit
500000
Annuals > 2 > income Statement > operating Expenses
2770368
Annuals > 2 > income Statement > operating Income
-2270368
Annuals > 2 > income Statement > interest Expense
15878
Annuals > 2 > income Statement > pretax Income
-2682108
Annuals > 2 > income Statement > net Income
-2682108
Annuals > 2 > income Statement > eps
-2.4859607267388513
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1078902
Annuals > 2 > income Statement > income Tax Expense
-250038
Annuals > 2 > income Statement > EBITDA
-2604958
Annuals > 2 > income Statement > operating Margin
-454.0736
Annuals > 2 > income Statement > total Other Income Expense Net
-411740
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
645000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
4000
Annuals > 2 > balance Sheet > inventories
-1791654
Annuals > 2 > balance Sheet > total Current Assets
2453000
Annuals > 2 > balance Sheet > property Plant Equipment
309467
Annuals > 2 > balance Sheet > total Assets
3241000
Annuals > 2 > balance Sheet > payables
568000
Annuals > 2 > balance Sheet > short Term Debt
7646000
Annuals > 2 > balance Sheet > long Term Debt
1617000
Annuals > 2 > balance Sheet > total Liabilities
20556000
Annuals > 2 > balance Sheet > equity
-17212000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2682108
Annuals > 2 > cash Flow > depreciation
61272
Annuals > 2 > cash Flow > change In Working Capital
-11939
Annuals > 2 > cash Flow > cash From Operations
-2075624
Annuals > 2 > cash Flow > capital Expenditures
9682
Annuals > 2 > cash Flow > cash From Investing
980937
Annuals > 2 > cash Flow > cash From Financing
1312070
Annuals > 2 > cash Flow > net Change In Cash
217383
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.4859607267388513
Annuals > 2 > ratios > PB
-0.13038090634441088
Annuals > 2 > ratios > ROE
15.582779456193355
Annuals > 2 > ratios > ROA
-82.75556926874421
Annuals > 2 > ratios > FCF
-2085306
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.170612
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3039184
Annuals > 3 > income Statement > cost Of Revenue
150000
Annuals > 3 > income Statement > gross Profit
3039184
Annuals > 3 > income Statement > operating Expenses
4670692
Annuals > 3 > income Statement > operating Income
-1631508
Annuals > 3 > income Statement > interest Expense
3094
Annuals > 3 > income Statement > pretax Income
-1264703
Annuals > 3 > income Statement > net Income
-1264703
Annuals > 3 > income Statement > eps
-1.1740390113848187
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1077224
Annuals > 3 > income Statement > income Tax Expense
3094
Annuals > 3 > income Statement > EBITDA
-1228241
Annuals > 3 > income Statement > operating Margin
-53.68243581171788
Annuals > 3 > income Statement > total Other Income Expense Net
366805
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
584000
Annuals > 3 > balance Sheet > short Term Investments
996447
Annuals > 3 > balance Sheet > receivables
25000
Annuals > 3 > balance Sheet > inventories
-1607147
Annuals > 3 > balance Sheet > total Current Assets
2234000
Annuals > 3 > balance Sheet > property Plant Equipment
514152
Annuals > 3 > balance Sheet > total Assets
3154000
Annuals > 3 > balance Sheet > payables
193000
Annuals > 3 > balance Sheet > short Term Debt
7140000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
15029000
Annuals > 3 > balance Sheet > equity
-11832000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1264703
Annuals > 3 > cash Flow > depreciation
33368
Annuals > 3 > cash Flow > change In Working Capital
-754791
Annuals > 3 > cash Flow > cash From Operations
-2250775
Annuals > 3 > cash Flow > capital Expenditures
108434
Annuals > 3 > cash Flow > cash From Investing
823321
Annuals > 3 > cash Flow > cash From Financing
1077245
Annuals > 3 > cash Flow > net Change In Cash
-350209
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.1740390113848187
Annuals > 3 > ratios > PB
-0.1893700067613252
Annuals > 3 > ratios > ROE
10.688835361730899
Annuals > 3 > ratios > ROA
-40.09838300570704
Annuals > 3 > ratios > FCF
-2359209
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.7762639576939073
Annuals > 3 > health Score
24
Valuation > metrics > PE
-0.44346648612051454
Valuation > metrics > PB
15.80222159090909
Valuation > final Score
20
Valuation > verdict
426.7% Overvalued
Profitability > metrics > ROE
-260.5113636363636
Profitability > metrics > ROA
-39.87996868748369
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
6.147159090909091
Risk > metrics > Interest Coverage
-1065.3333333333333
Risk > final Score
-4255
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.9884123140781735
Liquidity > metrics > Quick Ratio
1.9884123140781735
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
-2467
Prev Risks > 1
-1372
Prev Risks > 2
-1300
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:33:01.159Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.5135
Earnings History > 0 > eps Estimate
-0.53
Earnings History > 0 > eps Difference
0.0165
Earnings History > 0 > surprise Percent
3.1132
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-04
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.66
Earnings History > 1 > eps Estimate
-0.425
Earnings History > 1 > eps Difference
-0.235
Earnings History > 1 > surprise Percent
-55.2941
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.49
Earnings History > 2 > eps Estimate
-0.49
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.3561
Earnings History > 3 > eps Estimate
0.42
Earnings History > 3 > eps Difference
-0.7761
Earnings History > 3 > surprise Percent
-184.7857
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.1312
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.5124
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-3.3824
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-3.203
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-5.0052
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-2.4734
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-3.0369
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.07
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.06
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.07
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.07
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-29
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.06
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.05
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.07
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.05
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.06
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-16
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.07
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-14
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.07
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.08
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-30
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.07
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-14
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.09
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.08
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-04-01
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.09
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-3.1273
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-10-22
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.05
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.05
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-07-19
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.01
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.01
Earnings History > 29 > surprise Percent
-
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$13
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Serina Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.5135
EPS Estimate
-0.53
EPS Difference
0.0165
Surprise Percent
3.1132%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.